Pharmaceutical Raw Materials

Fostamatinibdisodiumhexahydrate; 6-[[5-Fluoro-2-[(3,4,5-Trimethoxyphenyl)Amino]-4-Pyrimidinyl]Amino]-2,2-Dimethyl-4-[(Phosphonooxy)Methyl]-2H-Pyrido[3,2-b]-1,4-Oxazin-3(4H)-Onedisodiumsalthexahydrate; Fostamatinibdisodiumsalthexahydrate; 6-[[5-Fluoro-2-[(3,4,5-Trimethoxyphenyl)Amino]-4-Pyrimidinyl]Amino]-2,2-Dimethyl-4-[(Phosphonooxy)Methyl]-2H-Pyrido[3,2-b]-1,4-Oxazin-3(4H)-Onesodiumsalthydrate;R788(Disodiumhexahydrate); Fostamatinibna; 2H-Pyrido[3,2-b]-1,4-Oxazin-3(4H)-one,6-[[5-Fluoro-2-[(3,4,5-Trimethoxyphenyl)Amino]-4-Pyrimidinyl]Amino]-2,2-Dimethyl-4-[(Phosphonooxy)Methyl]-,Disodiumsalt,Hexahydrate; R788Disodiumhexahydrate(Fostamatinibdisodiumhexahydrate); ; R788 Disodium Hexahydrate; R788 (Disodium Hexahydrate); 2H-Pyrido[3,2-b]-1,4-Oxazin-3(4H)-one, 6-[[5-Fluoro-2-[(3,4,5-Trimethoxyphenyl)Amino]-4-Pyrimidinyl]Amino]-2,2-Dimethyl-4-[(Phosphonooxy)Methyl]-, Disodium salt, Hexahydrate

Enroflxacin